Future Techly’s Post

The Expanding Reach of AI The medical imaging AI market has seen significant steady growth in recent years. Currently there are four subspecialties— cardiology, neurology, pulmonology and breast— that dominate the medical imaging AI market. But what about Women’s Health? Exciting improvements are also shaking up routine processes in obstetrics and gynaecology. AI tools can simplify and improve vital workflows for providers such as fetal heart exams, pelvic floor assessments, fetal anatomy identification and 3D fibroid mapping. At GE HealthCare, we are proud to offer innovative AI imaging technology in Women’s Health and will continue to set our focus on further development. Despite the rising demand, there are also some challenges facing the industry: especially in Europe stringent CE mark regulations are slowing down the implementation of AI technology, with only 11 CE mark approvals in Europe compared to 55 new FDA approvals in the US between July 2023 and June 2024. But even within Europe, AI medical imaging technology is successfully applied, and interest in AI imaging has also grown in the Middle East, mainly in Saudi Arabia. What makes AI particularly useful, are comprehensive AI solutions for entire subspecialties, which are also expected to be the future of the industry. #Voluson #Ultrasound #GEHealthCare #VolusonSignature #obstetrics #ultrasoundtechnology #sonography #innovation #AI #AIimaging

AI Revolutionizing Ophthalmology: A Leap Forward in Healthcare Recent research from the New York Eye and Ear Infirmary of Mount Sinai reveals a milestone achievement: AI, particularly the GPT-4 system, has matched or even exceeded human ophthalmologists in diagnosing and treating glaucoma and retina diseases. This landmark study, published in JAMA Ophthalmology, showcases the potential of AI to significantly enhance patient care by providing accurate, data-driven support to clinicians. Key findings highlight AI's superior performance in glaucoma case management and its equal footing in retina case accuracy, signaling a new era in healthcare where technology complements human expertise to improve outcomes. This synergy between AI and medical professionals can streamline diagnostics, treatment plans, and patient access to care. The implications of this study extend beyond ophthalmology, suggesting a transformative impact on the entire healthcare sector. As AI continues to evolve, its integration into medical practices promises to boost diagnostic and treatment efficiency and enrich the patient-care process. Let's embrace AI's role in advancing healthcare, advocating for a balanced approach where technology enhances, not replaces, the invaluable human element in medicine. Let's not just observe; let's participate! Whether you're a healthcare professional, tech enthusiast, or patient, you have a role in shaping this future. Share your thoughts, experiences, and hopes for AI in healthcare. Engage with the community, advocate for technology integration in medical practices, and support initiatives that bring these innovations to the forefront of patient care. Together, we can navigate this exciting journey towards a healthier tomorrow. 📌 #HealthcareAI #OphthalmologyInnovation #AIinMedicine #FutureOfHealthcare #PatientCareEvolution #MedicalTechnology

The Expanding Reach of AI The medical imaging AI market has seen significant steady growth in recent years. Currently there are four subspecialties— cardiology, neurology, pulmonology and breast— that dominate the medical imaging AI market. But what about Women’s Health? Exciting improvements are also shaking up routine processes in obstetrics and gynaecology. AI tools can simplify and improve vital workflows for providers such as fetal heart exams, pelvic floor assessments, fetal anatomy identification and 3D fibroid mapping. At GE HealthCare, we are proud to offer innovative AI imaging technology in Women’s Health and will continue to set our focus on further development. Despite the rising demand, there are also some challenges facing the industry: especially in Europe stringent CE mark regulations are slowing down the implementation of AI technology, with only 11 CE mark approvals in Europe compared to 55 new FDA approvals in the US between July 2023 and June 2024. But even within Europe, AI medical imaging technology is successfully applied, and interest in AI imaging has also grown in the Middle East, mainly in Saudi Arabia. What makes AI particularly useful, are comprehensive AI solutions for entire subspecialties, which are also expected to be the future of the industry. #Voluson #Ultrasound #GEHealthCare #VolusonSignature #obstetrics #ultrasoundtechnology #sonography #innovation #AI #AIimaging

Imbalances in medical research are an unfortunate reality. Many groups continue to be under-represented in research, including women, marginalised communities, people of colour, and the entire global South! Because of this, treatment protocols do not properly account for their needs, resulting in sub-optimal clinical care. One example of this is appendicitis, where there is a choice between open surgery and less invasive surgery. Less invasive operations allow patients to recover faster and with a lower probability of complications – improving their quality of life. Unfortunately, in low- and middle-income countries, like South Africa, it can be difficult for doctors to decide between the two operations because the decision is usually based on CT scans or ultrasounds, which are not always available. In these situations doctors often default to open surgery. What this means is that patients end up with a lower quality of life than their counterparts in high-income countries, who would have had the less invasive operation. Healthcare is unequal simply by accident of birth. Michael Brombacher has just published a study investigating how blood tests can inform when less invasive surgery for appendicitis is more appropriate than open surgery. Studies like these allow for better decision-making in settings where expensive imaging is not available, and are important for the advancement of healthcare in these contexts. Thanks for involving me in this work, and I look forward to many more!

I am pleased to share that our study related to "Exploring Clinical Specialists' Perspectives on the Future Role of AI: Evaluating Replacement Perceptions, Benefits, and Drawbacks" has been published online in BMC Health Services Research( IF = 2.8, Q1). Thanks to all co-authors especially Dr. Muhammad Daniyal. In a nutshell, This study will provide perspectives among different clinical specialties on the potential roles of AI in the healthcare sector of southern Punjab, Pakistan. Overall, a positive attitude towards AI emerged, with many participants acknowledging its transformative impact on the future of healthcare. This study observed widespread acknowledgment of AI's diagnostic capabilities and shared vision of its potential to enhance patient care, reduce workload, and integrate AI concepts into medical education, particularly in Surgery, Pathology, and Radiology specialties. Link https://lnkd.in/dVYD7Q5v #AI #clinicalstudies #medicalstudy #healthcare

New medical AI launches, from India to Korea - MobiHealthNews #NewMedicalAILaunches #India #Korea A recent wave of new medical AI launches has been observed in India and Korea, showcasing the growing influence of artificial intelligence in healthcare technology. #InnovativeSolutionsFromIndia In India, innovative AI solutions are being developed to revolutionize healthcare delivery and improve patient outcomes. #CuttingEdgeTechnologyInKorea Meanwhile, Korea is at the forefront of cutting-edge technology in the medical AI space, with new launches that are set to transform the healthcare landscape. #ImpactOnHealthcare These new medical AI launches are expected to have a significant impact on healthcare systems in both countries, paving the way for more efficient and effective patient care. #CollaborationOp ai.mediformatica.com #brain #medical #this #imaging #india #medicalimaging #patients #technology #clinicians #decisionsupport #neurosurgery #radiologists #digitalhealth #healthit #healthtech #healthcaretechnology @MediFormatica (https://buff.ly/3SO1q0Y)

China is developing an AI assistant to help brain surgeons. So far it has been tested in 7 hospitals. This tool is much needed for neurological surgery as the stakes are high. It can warn doctors of the risk factors and minimize the chance of failure. This AI model has been trained on Meta’s LLAMA 2.0. For better assistance, it has been fed with medical journals and manuals. The Chinese government supports this initiative, and hopefully the impact can be seen in the neurosurgery field pretty soon. It's still in its early phase and there are challenges like, restricted computing power and lack of high quality data. But if it works out, this could become a potential revolution for healthcare. It can be said that the day isn't far away when doctors will be talking to AI for better clinical decisions. What do you think? #aiinmedicine

𝐔𝐥𝐭𝐫𝐚𝐬𝐨𝐮𝐧𝐝 𝐁𝐨𝐧𝐞 𝐃𝐞𝐧𝐬𝐢𝐭𝐲 𝐃𝐞𝐭𝐞𝐜𝐭𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟎 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗙𝗼𝗿 𝗙𝗿𝗲𝗲 𝗦𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁, https://lnkd.in/gem6JseT 𝑻𝒉𝒆 𝑼𝒍𝒕𝒓𝒂𝒔𝒐𝒖𝒏𝒅 𝑩𝒐𝒏𝒆 𝑫𝒆𝒏𝒔𝒊𝒕𝒚 𝑫𝒆𝒕𝒆𝒄𝒕𝒐𝒓 𝑴𝒂𝒓𝒌𝒆𝒕 𝒊𝒔 𝒑𝒓𝒐𝒋𝒆𝒄𝒕𝒆𝒅 𝒕𝒐 𝒈𝒓𝒐𝒘 𝒂𝒕 𝒂 𝑪𝑨𝑮𝑹 𝒐𝒇 6.8% 𝒇𝒓𝒐𝒎 2024 𝒕𝒐 2030. 𝑻𝒉𝒆 𝒎𝒂𝒓𝒌𝒆𝒕 𝒔𝒊𝒛𝒆 𝒘𝒂𝒔 𝒗𝒂𝒍𝒖𝒆𝒅 𝒂𝒕 𝒂𝒑𝒑𝒓𝒐𝒙𝒊𝒎𝒂𝒕𝒆𝒍𝒚 𝑼𝑺𝑫 450 𝒎𝒊𝒍𝒍𝒊𝒐𝒏 𝒊𝒏 2023 𝒂𝒏𝒅 𝒊𝒔 𝒆𝒙𝒑𝒆𝒄𝒕𝒆𝒅 𝒕𝒐 𝒓𝒆𝒂𝒄𝒉 𝒂𝒓𝒐𝒖𝒏𝒅 𝑼𝑺𝑫 720 𝒎𝒊𝒍𝒍𝒊𝒐𝒏 𝒃𝒚 2030. An #UltrasoundBoneDensityDetector is a non-invasive medical device that uses ultrasound technology to measure bone mineral density (BMD). It assesses the quality and strength of bones, particularly in the heel or finger, to identify potential bone loss or osteoporosis. This device is often used as a screening tool for osteoporosis, especially in individuals at high risk, such as postmenopausal women and older adults. 𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝗿𝗶𝘃𝗲𝗿𝘀: • Rising prevalence of osteoporosis and osteopenia: Aging populations and sedentary lifestyles are contributing to an increase in bone-related diseases. • Early detection and prevention: Early diagnosis of bone density issues allows for timely intervention and preventive measures. • Non-invasive and painless procedure: Ultrasound bone density detectors offer a safe and comfortable alternative to traditional methods like DEXA scans. 𝗠𝗮𝗿𝗸𝗲𝘁 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀: • Expanding applications: Beyond osteoporosis screening, ultrasound bone density detectors can be used to monitor bone health in various populations, including athletes, post-menopausal women, and individuals with specific medical conditions. • Integration with telemedicine: Remote monitoring of bone health using portable ultrasound devices can improve accessibility and convenience. • Development of advanced algorithms: Improved data analysis and interpretation techniques can enhance the accuracy and clinical utility of ultrasound bone density measurements. 𝗠𝗮𝗿𝗸𝗲𝘁 𝘀𝗲𝗴𝗺𝗲𝗻𝘁 𝗯𝘆 𝗽𝗹𝗮𝘆𝗲𝗿𝘀, 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁 𝗰𝗼𝘃𝗲𝗿𝘀 pinyuan medical Furuno USA, Inc. GE HealthCare BeamMed Aarna Systems Pvt Ltd. STEMart Inc. BM Tech OSTEOSYS CO., LTD Hologic, Inc. 𝗘𝗻𝗾𝘂𝗶𝗿𝗲 𝗯𝗲𝗳𝗼𝗿𝗲 𝗽𝘂𝗿𝗰𝗵𝗮𝘀𝗶𝗻𝗴 𝘁𝗵𝗶𝘀 𝗿𝗲𝗽𝗼𝗿𝘁, https://lnkd.in/gVDxt_DJ Market intelliX Market Pulse Updates #UltrasoundTechnology #BoneDensity #MedicalDevices #ClinicalDiagnostics #HealthcareInnovation #Diagnostics #MedicalImaging #DiagnosticTools #BoneHealth #HealthTech #InnovationInMedicine #HealthcareIndustry #OsteoporosisPrevention #TechInHealthcare #MedicalAdvancements

Remidio’s Chief Medical Officer, Dr. Divya Rao, will be presenting our prospective real-world study on harnessing the role of AI to prevent Retinopathy of Prematurity (ROP) at the 4th annual Ophthalmic Artificial Intelligence (OAI) Summit. ROP is one of the leading causes of infant blindness, affecting more than 50,000 infants globally, while the number of ROP specialists are limited. Remidio’s AI for ROP hopes to provide accurate, efficient, and scalable screening solutions to prevent blindness in infants worldwide. This is the vision that drives our team! Hear Dr. Divya Rao share more about our work at the OAI Summit, a gathering that addresses what AI could do for the future of medicine and how it can impact the practice of ophthalmology today. #remidio #retinopathyofprematurity #ROP #babiesoftheworld #ophthalmology #OAI2024

🌟 Exciting Medical Breakthrough: The Power of Hand Transplantation 🌟 I'm thrilled to share a remarkable advancement in medical science that continues to inspire awe and hope—the successful hand transplant! 🤝 Recently, I had the privilege of learning about the groundbreaking hand transplant procedure, a testament to the incredible strides in surgical innovation and human perseverance. This transformative surgery not only restores physical function but also rekindles the spirit of individuals facing profound challenges. Hand transplantation represents a synergy of cutting-edge technology, meticulous surgical skill, and compassionate care, offering new possibilities for patients who have experienced limb loss. It underscores the resilience of the human spirit and the dedication of medical professionals who make such miracles possible. As we celebrate this achievement, let's also recognize the courage of patients and their families who embark on this journey, as well as the researchers, surgeons, and healthcare teams whose dedication paves the way for future breakthroughs in transplantation medicine. Let's continue to support and advocate for advancements that enhance quality of life and redefine what's possible in healthcare. Together, we can inspire hope and empower individuals to reach new heights of independence and vitality. #HandTransplant #MedicalInnovation #HealthcareAdvancement #Inspiration #PatientCare #LinkedInPost #Giridihdentist #India